Metropolitan Life Insurance Co. NY boosted its stake in Axcelis Technologies Inc (NASDAQ:ACLS) by 362.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,363 shares of the semiconductor company’s stock after buying an additional 8,121 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Axcelis Technologies were worth $184,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Bank of America Corp DE raised its stake in shares of Axcelis Technologies by 5.2% during the 4th quarter. Bank of America Corp DE now owns 119,620 shares of the semiconductor company’s stock worth $2,129,000 after purchasing an additional 5,900 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Axcelis Technologies by 7.6% during the 4th quarter. Geode Capital Management LLC now owns 375,416 shares of the semiconductor company’s stock worth $6,682,000 after purchasing an additional 26,452 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Axcelis Technologies by 10.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,285,935 shares of the semiconductor company’s stock worth $40,690,000 after purchasing an additional 208,263 shares in the last quarter. Northern Trust Corp raised its stake in shares of Axcelis Technologies by 0.3% during the 4th quarter. Northern Trust Corp now owns 396,001 shares of the semiconductor company’s stock worth $7,049,000 after purchasing an additional 1,144 shares in the last quarter. Finally, AlphaOne Investment Services LLC purchased a new stake in shares of Axcelis Technologies during the 4th quarter worth about $33,000. 85.64% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts recently weighed in on ACLS shares. Zacks Investment Research raised Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, February 11th. Craig Hallum downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, February 8th. BidaskClub raised Axcelis Technologies from a “sell” rating to a “hold” rating in a research note on Friday, December 28th. Benchmark raised Axcelis Technologies from a “hold” rating to a “buy” rating and set a $26.50 price objective on the stock in a research note on Friday, February 8th. Finally, B. Riley raised Axcelis Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the company from $18.00 to $28.00 in a research note on Monday, January 28th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $26.70.
Shares of ACLS stock opened at $21.60 on Wednesday. Axcelis Technologies Inc has a twelve month low of $15.46 and a twelve month high of $25.20. The company has a market capitalization of $702.49 million, a P/E ratio of 16.34 and a beta of 1.19.
Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings data on Wednesday, February 6th. The semiconductor company reported $0.25 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.20 by $0.05. Axcelis Technologies had a return on equity of 11.39% and a net margin of 10.37%. The business had revenue of $105.68 million for the quarter, compared to the consensus estimate of $99.83 million. During the same period last year, the business earned $0.47 EPS. The firm’s revenue was down 9.2% compared to the same quarter last year. On average, research analysts predict that Axcelis Technologies Inc will post 0.83 earnings per share for the current fiscal year.
Axcelis Technologies announced that its board has initiated a share buyback plan on Monday, January 14th that allows the company to repurchase $35.00 million in outstanding shares. This repurchase authorization allows the semiconductor company to reacquire up to 5.8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
In other Axcelis Technologies news, Director R John Fletcher sold 22,500 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $20.26, for a total value of $455,850.00. Following the sale, the director now owns 58,372 shares of the company’s stock, valued at approximately $1,182,616.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Dennis Thomas St sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 20th. The shares were sold at an average price of $22.43, for a total value of $112,150.00. The disclosure for this sale can be found here. Insiders sold a total of 41,172 shares of company stock worth $875,757 over the last three months. 3.72% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by Macon Daily and is the property of of Macon Daily. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://macondaily.com/2019/04/17/metropolitan-life-insurance-co-ny-has-184000-holdings-in-axcelis-technologies-inc-acls.html.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.
Read More: New Google Finance Tool and Screening Stocks
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies Inc (NASDAQ:ACLS).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.